A better understanding of how GATA2 and GATA3 function as oncogenes or tumor suppressors is of prime importance for the treatment of neuroblastoma and urothelial cancers and will shed further light on their roles as prognostic factors. This evidence concerns the gene GATA3 and neuroblastoma.